Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.695
-0.005 (-0.29%)
Aug 14, 2025, 2:16 PM - Market open
Aclaris Therapeutics Employees
As of December 31, 2024, Aclaris Therapeutics had 64 total employees, including 61 full-time and 3 part-time employees. The number of employees decreased by 27 or -29.67% compared to the previous year.
Employees
64
Change (1Y)
-27
Growth (1Y)
-29.67%
Revenue / Employee
$262,328
Profits / Employee
-$2,103,938
Market Cap
183.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACRS News
- 7 days ago - Aclaris Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 15 days ago - Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints - GlobeNewsWire
- 17 days ago - Aclaris Therapeutics Announces Leadership Transition - GlobeNewsWire
- 6 weeks ago - Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 6 weeks ago - Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference - GlobeNewsWire
- 7 weeks ago - Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052 - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics to Participate in Two June Healthcare Conferences - GlobeNewsWire
- 3 months ago - Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series - GlobeNewsWire